After hours
You're reading the free version. Trader adds the live tape and alerts. Start tracking

7 trades

Disclosure transactions for Lixte Biotechnology Holdings, Inc.
Reporting person Filed Transaction Transaction value Source Actions
Stazzone Peter Chief Financial Officer Jul 2, 2026 1-day lag Award Jul 1, 2026 $0 Filed shares x price SEC Form 4 View filing
Sawyer Jason David Director Jul 2, 2026 1-day lag Award Jul 1, 2026 $0 Filed shares x price SEC Form 4 View filing
Holloway Michael Andrew Director Jul 2, 2026 1-day lag Award Jul 1, 2026 $0 Filed shares x price SEC Form 4 View filing
Felix Lourdes Director Jul 2, 2026 1-day lag Award Jul 1, 2026 $0 Filed shares x price SEC Form 4 View filing
Primus Guy Warren Director Jul 2, 2026 1-day lag Award Jul 1, 2026 $0 Filed shares x price SEC Form 4 View filing
Pursglove Geordan Garrett CEO And Chairman Of The Board Jul 2, 2026 1-day lag Award Jul 1, 2026 $0 Filed shares x price SEC Form 4 View filing
Porter Stuart D Director Jun 1, 2026 3-day lag Award May 29, 2026 $0 Filed shares x price SEC Form 4 View filing
Stazzone Peter Chief Financial Officer
Award
Calculated transaction value
$0 50,000 shares @ $0
Traded
Jul 1, 2026
Filed
Jul 2, 2026
Sawyer Jason David Director
Award
Calculated transaction value
$0 40,000 shares @ $0
Traded
Jul 1, 2026
Filed
Jul 2, 2026
Holloway Michael Andrew Director
Award
Calculated transaction value
$0 15,000 shares @ $0
Traded
Jul 1, 2026
Filed
Jul 2, 2026
Felix Lourdes Director
Award
Calculated transaction value
$0 30,000 shares @ $0
Traded
Jul 1, 2026
Filed
Jul 2, 2026
Primus Guy Warren Director
Award
Calculated transaction value
$0 15,000 shares @ $0
Traded
Jul 1, 2026
Filed
Jul 2, 2026
Pursglove Geordan Garrett CEO And Chairman Of The Board
Award
Calculated transaction value
$0 350,000 shares @ $0
Traded
Jul 1, 2026
Filed
Jul 2, 2026
Porter Stuart D Director
Award
Calculated transaction value
$0 25,000 shares @ $0
Traded
May 29, 2026
Filed
Jun 1, 2026